HSV-2 gG Antibodies

Santa Cruz Biotechnology features a diverse variety of HSV-2 gG monoclonal antibodies for research focused on understanding glycoprotein G in herpes simplex virus type 2. HSV-2 gG Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein G (gG) serves as a critical component of the HSV-2 envelope, playing a significant role in viral entry and immune evasion. HSV-2 gG contributes to the virus's ability to establish latency and reactivation, making it a key target for therapeutic interventions and vaccine development. Understanding HSV-2 gG function is essential for advancing knowledge of herpes simplex virus pathogenesis and improving clinical outcomes for affected individuals. Researchers can explore viral mechanisms, track protein expression patterns, and investigate potential therapeutic approaches using specific molecular tools. Advanced research techniques and reliable detection methods help unlock new insights into viral biology and disease progression. HSV-2 gG monoclonal antibodies from Santa Cruz Biotechnology enable scientists worldwide to advance their research and contribute meaningful discoveries to the scientific community.